Systemic and Vascular Oxidation Limits the Efficacy of Oral Tetrahydrobiopterin Treatment in Patients With Coronary Artery Disease
Circulation - United States
doi 10.1161/circulationaha.111.038919
Full Text
Open PDFAbstract
Available in full text
Date
March 20, 2012
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)